1-(4,6-Dimethylpyrimidin-2-yl)-3-(4-methoxyphenyl)guanidine

Catalog No.: 
ACXUNQ347
CAS No.: 
34747-52-9
Molecular Formula: 
C14H17N5O
Molecular Weight: 
271.32
1-(4,6-Dimethylpyrimidin-2-yl)-3-(4-methoxyphenyl)guanidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$256.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4,6-Dimethylpyrimidin-2-yl)-3-(4-methoxyphenyl)guanidine
IUPAC Name2-(4,6-dimethylpyrimidin-2-yl)-1-(4-methoxyphenyl)guanidine
MDL No.MFCD01171444
Molecular FormulaC14H17N5O
Molecular Weight271.32
SMILESN=C(NC1=CC=C(OC)C=C1)NC2=NC(C)=CC(C)=N2
InChI KeyOCSYLDRRDZUXOP-UHFFFAOYSA-N
SynonymAKOS BBS-00005701;ASISCHEM C58429;N-(4,6-Dimethylpyrimidin-2-yl)-N'-(4-methoxyphenyl)guanidine;1-(4,6-Dimethylpyrimidin-2-yl)-3-(4-methoxyphenyl)guanidine;Guanidine, N-(4,6-dimethyl-2-pyrimidinyl)-N'-(4-methoxyphenyl)-
CAS No.34747-52-9

Synthetic Route by SureRoute

1. ACXUNQ347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMALW908 route compound structure diagram
    ACMALW9084472-44-0In Stock
  4. Then
  5. ACXUNQ347 route product structure diagram
    ACXUNQ34734747-52-9
Inquiry

2. ACXUNQ347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSIGC147 route compound structure diagram
    ACSIGC14720265-97-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXUNQ347 route product structure diagram
    ACXUNQ34734747-52-9
Inquiry

3. ACXUNQ347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAXJY543 route compound structure diagram
    ACAXJY543767-15-7In Stock
  4. Then
  5. ACXUNQ347 route product structure diagram
    ACXUNQ34734747-52-9
Inquiry

Comments (0)